'Watch out for Aurobindo Pharma and Panacea Biotec in mid-cap pharma space'

In a chat with ET Now, Seshadri Bharathan, MD & CEO, KSEMA Fincon Ltd., talks about the outlook of the mid-cap pharma stocks.

ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › 'Watch out for Aurobindo Pharma and Panacea Biotec in mid-cap pharma space'
Text Size:AAA
Success
This article has been saved

*

+